Article Versions Notes

Kalisch Ellett LM, Moffat AK, Gadzhanova S, Pratt NL, Apajee J, Woodward M, Roughead EE. Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines. Pharmacy. 2019; 7(3):100. https://doi.org/10.3390/pharmacy7030100

Kalisch Ellett, Lisa M, Anna K Moffat, Svetla Gadzhanova, Nicole L Pratt, Jemisha Apajee, Michael Woodward, and Elizabeth E Roughead. 2019. "Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines" Pharmacy 7, no. 3: 100. https://doi.org/10.3390/pharmacy7030100

Kalisch Ellett, L. M., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (2019). Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines. Pharmacy, 7(3), 100. https://doi.org/10.3390/pharmacy7030100